Treatment of Erythrodermic Psoriasis in Children with Secukinumab: A Case Report

Figures & data

Figure 1 (a–c) Upon admission on April 7, the patient’s whole body was covered with dense pustules, local congestion was evident, dandruff and dry scabs were scattered, and some abscesses coalesced into the blemish.

Table 1 Changes in Laboratory Examination Indices

Project	When Admitted to the Hospital on April 7th	Before the Injection on April 29th	After the Injection on May 2nd	Before Discharge on May 6th
White blood cell	9.39 x10^9/L	23.62 x10^9/L	7.54 x10^9/L	9.28 x10^9/L
Hemoglobin	107 g/L	122 g/L	107 g/L	110 g/L
C-reactive protein	52.04 mg/L	18.28 mg/L	11.13 mg/L	2.29 mg/L
Erythrocyte sedimentation rate	-	22 mm	26 mm	11mm
D-dimer	380 ng/mL	400 ng/mL	151 ng/mL	-

Figure 2 (a–c) Skin flushing in the forechest due to EP on April 25 gradually spread to the entire body, accompanied by dry yellow scabs and an absence of obvious pustules.

Figure 3 (a–c) By May 27, the child had nearly completely cleared the skin lesions, with the skin lesions improving to a PASI 90 score.